vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and Tecnoglass Inc. (TGLS). Click either name above to swap in a different company.
Tecnoglass Inc. is the larger business by last-quarter revenue ($245.3M vs $208.9M, roughly 1.2× iRhythm Holdings, Inc.). Tecnoglass Inc. runs the higher net margin — 10.6% vs 2.7%, a 8.0% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 2.4%). iRhythm Holdings, Inc. produced more free cash flow last quarter ($14.5M vs $11.4M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 12.8%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Tecnoglass Inc. is a leading manufacturer of high-performance architectural glass, aluminum windows, doors, and associated building components. It primarily caters to residential and commercial construction sectors across North America and Latin America, offering custom, energy-efficient solutions for new construction and renovation projects.
IRTC vs TGLS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $245.3M |
| Net Profit | $5.6M | $26.1M |
| Gross Margin | 70.9% | 40.0% |
| Operating Margin | 1.1% | 18.3% |
| Net Margin | 2.7% | 10.6% |
| Revenue YoY | 27.1% | 2.4% |
| Net Profit YoY | 518.5% | -44.5% |
| EPS (diluted) | $0.18 | $0.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $245.3M | ||
| Q3 25 | $192.9M | $260.5M | ||
| Q2 25 | $186.7M | $255.5M | ||
| Q1 25 | $158.7M | $222.3M | ||
| Q4 24 | $164.3M | $239.6M | ||
| Q3 24 | $147.5M | $238.3M | ||
| Q2 24 | $148.0M | $219.7M | ||
| Q1 24 | $131.9M | $192.6M |
| Q4 25 | $5.6M | $26.1M | ||
| Q3 25 | $-5.2M | $47.2M | ||
| Q2 25 | $-14.2M | $44.1M | ||
| Q1 25 | $-30.7M | $42.2M | ||
| Q4 24 | $-1.3M | $47.0M | ||
| Q3 24 | $-46.2M | $49.5M | ||
| Q2 24 | $-20.1M | $35.0M | ||
| Q1 24 | $-45.7M | $29.7M |
| Q4 25 | 70.9% | 40.0% | ||
| Q3 25 | 71.1% | 42.7% | ||
| Q2 25 | 71.2% | 44.7% | ||
| Q1 25 | 68.8% | 43.9% | ||
| Q4 24 | 70.0% | 44.5% | ||
| Q3 24 | 68.8% | 45.8% | ||
| Q2 24 | 69.9% | 40.8% | ||
| Q1 24 | 66.3% | 38.8% |
| Q4 25 | 1.1% | 18.3% | ||
| Q3 25 | -4.4% | 25.1% | ||
| Q2 25 | -10.0% | 24.0% | ||
| Q1 25 | -20.5% | 26.7% | ||
| Q4 24 | -2.5% | 28.0% | ||
| Q3 24 | -34.1% | 28.4% | ||
| Q2 24 | -15.5% | 23.3% | ||
| Q1 24 | -28.9% | 21.3% |
| Q4 25 | 2.7% | 10.6% | ||
| Q3 25 | -2.7% | 18.1% | ||
| Q2 25 | -7.6% | 17.3% | ||
| Q1 25 | -19.3% | 19.0% | ||
| Q4 24 | -0.8% | 19.6% | ||
| Q3 24 | -31.3% | 20.8% | ||
| Q2 24 | -13.6% | 15.9% | ||
| Q1 24 | -34.6% | 15.4% |
| Q4 25 | $0.18 | $0.57 | ||
| Q3 25 | $-0.16 | $1.01 | ||
| Q2 25 | $-0.44 | $0.94 | ||
| Q1 25 | $-0.97 | $0.90 | ||
| Q4 24 | $-0.03 | $1.00 | ||
| Q3 24 | $-1.48 | $1.05 | ||
| Q2 24 | $-0.65 | $0.75 | ||
| Q1 24 | $-1.47 | $0.63 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $104.1M |
| Total DebtLower is stronger | — | $174.4M |
| Stockholders' EquityBook value | $152.7M | $713.1M |
| Total Assets | $1.0B | $1.3B |
| Debt / EquityLower = less leverage | — | 0.24× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | $104.1M | ||
| Q3 25 | $565.2M | $127.1M | ||
| Q2 25 | $545.5M | $140.9M | ||
| Q1 25 | $520.6M | $160.2M | ||
| Q4 24 | $535.6M | $137.5M | ||
| Q3 24 | $522.0M | $124.8M | ||
| Q2 24 | $561.5M | $129.5M | ||
| Q1 24 | $569.1M | $138.8M |
| Q4 25 | — | $174.4M | ||
| Q3 25 | — | $114.7M | ||
| Q2 25 | — | $110.6M | ||
| Q1 25 | — | $110.6M | ||
| Q4 24 | — | $111.1M | ||
| Q3 24 | — | $126.8M | ||
| Q2 24 | — | $144.7M | ||
| Q1 24 | — | $160.9M |
| Q4 25 | $152.7M | $713.1M | ||
| Q3 25 | $121.9M | $764.0M | ||
| Q2 25 | $103.7M | $736.0M | ||
| Q1 25 | $86.7M | $685.1M | ||
| Q4 24 | $90.9M | $631.2M | ||
| Q3 24 | $71.8M | $613.3M | ||
| Q2 24 | $99.2M | $574.8M | ||
| Q1 24 | $90.3M | $573.6M |
| Q4 25 | $1.0B | $1.3B | ||
| Q3 25 | $995.2M | $1.2B | ||
| Q2 25 | $964.0M | $1.2B | ||
| Q1 25 | $926.1M | $1.1B | ||
| Q4 24 | $931.4M | $1.0B | ||
| Q3 24 | $909.7M | $996.3M | ||
| Q2 24 | $919.2M | $942.5M | ||
| Q1 24 | $909.8M | $981.6M |
| Q4 25 | — | 0.24× | ||
| Q3 25 | — | 0.15× | ||
| Q2 25 | — | 0.15× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.18× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.25× | ||
| Q1 24 | — | 0.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $31.0M |
| Free Cash FlowOCF − Capex | $14.5M | $11.4M |
| FCF MarginFCF / Revenue | 6.9% | 4.7% |
| Capex IntensityCapex / Revenue | 5.6% | 8.0% |
| Cash ConversionOCF / Net Profit | 4.70× | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $31.0M | ||
| Q3 25 | $34.9M | $40.0M | ||
| Q2 25 | $27.7M | $17.9M | ||
| Q1 25 | $-7.9M | $46.9M | ||
| Q4 24 | $19.2M | $61.1M | ||
| Q3 24 | $24.3M | $41.5M | ||
| Q2 24 | $11.8M | $34.5M | ||
| Q1 24 | $-52.0M | $33.4M |
| Q4 25 | $14.5M | $11.4M | ||
| Q3 25 | $20.1M | $21.2M | ||
| Q2 25 | $17.3M | $-14.7M | ||
| Q1 25 | $-17.3M | $16.5M | ||
| Q4 24 | $12.4M | $35.4M | ||
| Q3 24 | $15.5M | $17.8M | ||
| Q2 24 | $3.4M | $14.2M | ||
| Q1 24 | $-61.8M | $23.6M |
| Q4 25 | 6.9% | 4.7% | ||
| Q3 25 | 10.4% | 8.2% | ||
| Q2 25 | 9.3% | -5.7% | ||
| Q1 25 | -10.9% | 7.4% | ||
| Q4 24 | 7.5% | 14.8% | ||
| Q3 24 | 10.5% | 7.5% | ||
| Q2 24 | 2.3% | 6.5% | ||
| Q1 24 | -46.8% | 12.2% |
| Q4 25 | 5.6% | 8.0% | ||
| Q3 25 | 7.7% | 7.2% | ||
| Q2 25 | 5.6% | 12.7% | ||
| Q1 25 | 5.9% | 13.7% | ||
| Q4 24 | 4.2% | 10.7% | ||
| Q3 24 | 6.0% | 9.9% | ||
| Q2 24 | 5.7% | 9.2% | ||
| Q1 24 | 7.4% | 5.1% |
| Q4 25 | 4.70× | 1.19× | ||
| Q3 25 | — | 0.85× | ||
| Q2 25 | — | 0.41× | ||
| Q1 25 | — | 1.11× | ||
| Q4 24 | — | 1.30× | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.98× | ||
| Q1 24 | — | 1.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
TGLS
| Product Sales | $164.2M | 67% |
| Fixed Price Contracts | $81.1M | 33% |
| Related Party | $692.0K | 0% |
